医学
吉西他滨
新辅助治疗
佐剂
辅助化疗
随机对照试验
外科
放化疗
化疗
胰腺癌
胰腺切除术
辅助治疗
肿瘤科
阶段(地层学)
切除术
放射治疗
临床试验
总体生存率
内科学
作者
Eva Versteijne,Jacob L. van Dam,Mustafa Suker,Quisette P. Janssen,Karin Groothuis,Janine M. Akkermans-Vogelaar,Marc G. Besselink,Bert A. Bonsing,Jeroen Buijsen,Olivier R. Busch,Geert-Jan M. Creemers,Ronald M. van Dam,Ferry A. L. M. Eskens,Sebastiaan Festen,Jan Willem B. de Groot,Bas Groot Koerkamp,Ignace H. de Hingh,Marjolein Y. V. Homs,Jeanin E. van Hooft,Emile D. Kerver
摘要
Neoadjuvant gemcitabine-based chemoradiotherapy followed by surgery and adjuvant gemcitabine improves OS compared with upfront surgery and adjuvant gemcitabine in resectable and borderline resectable pancreatic cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI